首页> 外国专利> MEDICINE FOR AUTOIMMUNE DISEASE CONTAINING SOLUBLE FAS LIGAND AS EFFECTIVE INGREDIENTS

MEDICINE FOR AUTOIMMUNE DISEASE CONTAINING SOLUBLE FAS LIGAND AS EFFECTIVE INGREDIENTS

机译:含有可溶性FAS配体作为有效成分的自身免疫性疾病的药物

摘要

PURPOSE: A medicine for autoimmune disease containing soluble Fas ligand as effective ingredients is provided, which kills memory T lymphocytes representing Fas that can induce various immune diseases using soluble Fas ligand, so can be used to treat various immune diseases such as diabetes, rheumatoid arthritis. CONSTITUTION: A process for the preparation of soluble Fas ligand comprises: binding CD5 signal sequence to 34th amino acid located on the down side of transmembrane region of human Fas ligand; culturing transformated clones in non-serum medium(CHO-S-SFM II); and collecting supernatant as soluble Fas ligand. The medicine for autoimmune disease containing soluble Fas ligand as effective ingredients can be prepared in the form of injection type, for oral type. In a mouse experiment, the soluble Fas ligand decreases representation of Fas in CD4+ CD45RBlo Fas+ cells.
机译:目的:提供一种以可溶性Fas配体为有效成分的自身免疫性疾病药物,该药物可杀死代表Fas的记忆T淋巴细胞,从而利用可溶性Fas配体诱导多种免疫疾病,因此可用于治疗多种免疫疾病,例如糖尿病,类风湿性关节炎。组成:可溶性Fas配体的制备方法包括:将CD5信号序列与位于人Fas配体跨膜区下侧的第34个氨基酸结合。在非血清培养基(CHO-S-SFM II)中培养转化克隆;并收集上清液作为可溶性Fas配体。含有可溶性Fas配体作为有效成分的自身免疫疾病药物可以以注射型,口服型制备。在小鼠实验中,可溶性Fas配体降低了CD4 + CD45RBlo Fas +细胞中Fas的表达。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号